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Objectives: We evaluated Copan FLOQSwabs next to Abbott swabs for the detection of Chlamydia tracho-
matis (CT) by Abbott RealTime PCR.
Methods: We collected 1062 paired swabs from female sex workers. The study was divided in two arms,
according to the order of swab collection.
Results: If the Abbott swab was collected first, 501 couples were concordant and two discordant (Abbott
negative and Copan positive). If the Copan swab was collected first, 537 couples were concordant and 10
discordant (eight Abbott negative and Copan positive and two Abbott positive and Copan negative). All
discordant samples contained low levels of C. trachomatis. Technical issues lead to retesting of 64
Copan and 21 Abbott swabs.
Conclusion: Our results show that Copan FLOQSwabs can be used interchangeably with Abbott swabs.
While appearing to have an advantage in detecting more positive samples, the use of Copan swabs
led to a higher retesting rate due to technical errors.
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Introduction
Sexually transmitted infections (STIs) are a major
public health concern. Worldwide, Chlamydia tracho-
matis (CT) is the most common bacterium respon-
sible for STIs. Risk factors include high frequency
of partner change, multiple partners, unprotected
sex and being unmarried.1 In the USA, C. trachoma-
tis continues to be the most commonly reported noti-
fiable disease. Remarkably, in 2013, the rate of
reported cases decreased for the first time since the
start of national reporting in 1993.2 In Europe, an
overall increasing trend in the number of reported
C. trachomatis cases was seen from 1990 to 2009.
Since then, the overall rate has slightly decreased,
with the main reason being that Bulgaria started
reporting very low rates of C. trachomatis.3 Belgian
passive surveillance systems for C. trachomatis
show a continuous increase in incidence since
2002.4 It is presumed that those data are even
underestimated due to dependence on the quality of
STI services, the intensity of case finding and diagno-
sis, the quality of reporting and the extent to which
patients seek health care. Indeed, a large number of
STIs are asymptomatic and only part of the sympto-
matic population consult a physician. If left
untreated, C. trachomatis infections can lead to
severe complications, mainly in young women, such
as pelvic inflammatory disease, ectopic pregnancy
and tubal factor infertility.5 The Centre for Disease
Control and Prevention (CDC) guidelines call for
routine screening of all sexually active women
between ages 15 and 24, irrespective of symptoms.
The rationale is triple: most genital C. trachomatis
infections are asymptomatic; C. trachomatis preva-
lence is the highest in this group; C. trachomatis
related complications can be prevented by screening
and treatment of those infected.6
A variety of nucleic acid amplification tests
(NAATs) to detect C. trachomatis in (self-collected)
urethral, urine, vaginal and cervical specimens are
currently available with far higher sensitivity than
previously available diagnostic tests, such as culture,
antigen detection and nucleic acid hybridisation.
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However, concerns have raised about their speci-
ficity, particularly when screening low-prevalence
populations. Indeed, some studies could not repro-
duce positive NAAT results.6–11 Those findings led
the CDC to recommend confirmatory testing of posi-
tive NAAT results with a second NAAT (with equal
sensitivity) when the positive predictive value (PPV)
is below 90%.6,12 Another significant concern with
regard to the performance of NAATs has been the
cellular adequacy of the cervical specimen, since C.
trachomatis is an intracellular organism, targetting
the columnar epithelial cells. To assure efficient
(self-)sample collection, a variety of rayon, cotton
and flocked swabs have been developed, including
the swabs developed by the manufacturer of the
NAAT. This variety has a beneficial impact on the
accessibility of STI testing for healthcare providers.
In Belgium, an outreach health programme target-
ting sex workers has been set up for the Flemish
region, which is named PASOP. Within this pro-
gramme, the health team offers screening for STIs,
a cervical smear and vaccination against hepatitis
B. C. trachomatis testing is performed on first contact
as part of basic STI screening, after a perceived risk
(e.g. condom breakage) or when signs and symptoms
are present. Those positive are treated or referred for
treatment and the importance of partner treatment is
emphasised.13 The PASOP population was the sub-
ject of our study. The first objective was to evaluate
the interchangeability of Copan FLOQSwabs
(Copan Italia, Brescia, Italy) and the manufacturer
recommended Abbott swabs (Abbott Laboratories,
Illinois, USA) for the subsequent detection of C. tra-
chomatis by Abbott RealTime C. trachomatis PCR in
vaginal samples of 1062 Belgian sex workers. Second,
we wanted to investigate whether the use of flocked
swabs improved the detection of C. trachomatis in
this population.
Methods
The population of the current study consists of
female sex workers, embedded in an outreach
health programme for sex workers in Flanders
(PASOP). Between April 2011 and January 2013,
each female provided vaginal samples for the detec-
tion of C. trachomatis. A couple of two swabs were
consecutively collected: an Abbott swab and a
Copan FLOQSwab. Each swab was transported indi-
vidually in Abbott collection medium, and samples
were stored at (20uC prior to analysis. In the first
half of the study, from 6th April 2011 to 23rd
February 2012, the Abbott swab was collected
before the Copan swab (n5509). From 24th
February 2012 to 4th January 2013, the Copan
swab was the first one collected, followed by the
Abbott swab (n5553). Samples were tested for
C. trachomatis by the Abbott RealTime C. trachoma-
tis PCR on m2000sp and m2000rt instruments,
according to the manufacturer’s instructions. This
assay reports a qualitative result (negative or posi-
tive) as well as DC-value, indicative for the bacterial
load. The DC-value is the difference between the
cycle threshold (Ct) of the internal cutoff control
and the Ct of the sample. The higher the bacterial
load is, the larger the difference between both Cts
and the higher the DC. Each sample was retested
in the case of a failed internal control (internal con-
trol error) or a C. trachomatis bacterial load below
the limit of quantification (beyond cutoff error),
whenever enough sample was available. As the
PASOP population concerns anonymised subjects
receiving preventive healthcare services on a volunta-
rily basis and are not connected to the Ghent Univer-
sity Hospital whatsoever, no ethical clearance was
submitted at the ethical committee of the Ghent Uni-
versity Hospital.
Results
During 21months, a total of 1062 couples of swabs
were collected from female sex workers, embedded
in a Belgian outreach health programme. The study
was divided in two arms, according to the order of
swab collection. The results of the C. trachomatis
analyses are presented in Fig. 1. If the Abbott swab
was collected first, 32 coupled samples were both
positive, 446 both negative and 31 samples needed
retesting. Due to exhaustion of the specimen’s
volume, retesting was impossible in 6/31 samples.
Of the remaining 25 samples, one was positive con-
cordant, 20 were negative concordant, two showed
an A{Cz discordance (negative on the Abbott
swab and positive on the Copan swab) and two
were to be retested, both finally negative concordant.
If the Copan swab was collected first, 32 coupled
samples were both positive, 478 both negative,
three were A{Cz discordant and 40 needed retest-
ing. There was sufficient sample for retesting in 35/40
samples, of which three were positive concordant, 23
were negative concordant, three were A{Cz discor-
dant, one was AzC{ discordant (positive on the
Abbott swab and negative on the Copan swab) and
five were to be retested. As one sample was
yet fully used, only 4/5 could be retested, of
which one was positive concordant, two showed an
A{Cz discordance and one showed an AzC{ dis-
cordance. When comparing DC values of concordant
positive samples, a statistical difference was observed
(P-value 0.00028 first arm; P-value 0.00015second
arm) with analyses on Copan swabs systematically
resulting in higher DC values, indicating the better
sensitivity (Fig. 2).
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The number of errors leading to retesting for each
swab is listed in Table 1. During the whole study, the
majority of all retests was due to automatical errors by
m2000-instruments with the Copan swab (29/34 in the
first arm and 35/51 in the second arm). An internal con-
trol error was the number one reason for retesting (23/29
in the first arm and 31/35 in the second arm), followed by
a beyond cutoff error (6/29 in the first armand 4/35 in the
second arm). Of all 21 Abbott-retests, a beyond cutoff
error was the only cause of retesting. The order of
sampling seems to influence the error rate, as the
Abbott swab gave significantly more errors when it was
taken after the Copan swab (5 vs 16). However, this
increasewas less obviouswith theCopan swab (29 vs 35).
Discussion
In our study, we evaluated the interchangeability of
Copan FLOQSwabs and Abbott swabs for the sub-
sequent detection of C. trachomatis in vaginal
samples of 1062 Belgian sex workers. Second, we
investigated a possible improvement in detection of
C. trachomatis using flocked swabs instead of
Abbott swabs in this population. In total, 969
(85.0%) of the swabs were negative concordant; 69
(6.1%) were positive concordant; 10 (0.9%) were posi-
tive on the Copan swab but negative on the Abbott
swab (A{Cz) and two (0.2%) were positive on
the Abbott swab but negative on the Copan swab
(AzC{). The preponderance of A{Cz discor-
dances suggests the higher sensitivity of analysis on
Copan swabs. In fact, all discordant samples had a
Figure 1 Overview of the results for each study arm. Left panel: Abbott swab collected before Copan swab. Right panel:
Copan swab collected before Abbott swab (light grey background: concordance between both swabs; dark grey background:
discordance between both swabs).
Figure 2 Graphical outline of the DC values of the samples
both positive with Abbott and Copan (A Abbott swab col-
lected before Copan swab; B Copan swab collected before
Abbott swab).
Table 1 Number of errors leading to retesting for each arm
of the study and for each swab.
1st A–2nd C 1st C–2nd A
C A C A
IC-error 23 (0/23) None 31 (2/31) None
CO-error 6 (1/6) 5 (1/5) 4 (2/4) 16 (4/16)
Sum 29 (1/29) 5 (1/5) 35 (4/35) 16 (4/16)
A: Abbott swab; C: Copan swab; IC: internal control; CO:
beyond cutoff; numbers within brackets: combined Abbott/Co-
pan errors.
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weak positive test result. This hypothesis is affirmed
by the systematically higher DC values measured
on Copan swabs, resulting in a significant difference
between samples positive both on Copan and
Abbott swabs.
The clinical background of the patients with dis-
cordant results was retrieved. Within the A{Cz
group (n510), two patients were symptomatic and
eight were asymptomatic. Of those asymptomatic
females, one was recently treated for C. trachomatis
and four were known to display risk behaviour.
Within the AzC{ group (n52), one patient was
symptomatic and one was asymptomatic. However,
as mentioned previously, symptoms are no conditio
sine qua non for C. trachomatis infections. Differences
in C. trachomatis load have been associated with the
presence of clinical symptoms, the transmissibility
and persistence of infection, the risk of developing
chronic sequelae and the existence of multidrug
resistance. The asymptomatic nature of the disease
and risk of severe complications emphasise the criti-
cal role of sensitive and reliable diagnostic laboratory
methods.14,15
When comparing both study arms, comparable
numbers needed to be retested due to technical
issues, such as internal control errors or beyond
cutoff results. Most retests (64/85 or 75.3%) were
attributed to errors with the Copan swab, with
internal control issues being the main reason for
retesting (54/64 or 84.4%). From a technical point
of view, it is plausible to assume a link between the
higher retest rate and the higher sensitivity of anal-
ysis on the Copan swabs. The discordant results left
aside, the prevalence of C. trachomatis in our study
population was 6.7%, which is comparable but
lower than the 7.5% found in a previous study of
the same population in 2005.13 This prevalence is
lower than recorded in immigrant sex workers in
Italy (11%) and in registered sex workers in Mexico
(14.5%), though higher than reported in the Czech
Republic (5.5%), in Belgian general practices (5.0%)
and in general population in Britain (1.5%) and the
Netherlands (2.9%).13 The prevalence found in our
study (6.7%), combined with the test specifications
stated in the package insert of the Abbott RealTime
C. trachomatis assay (sensitivity of 95.2% and speci-
ficity of 99.3%), results in a PPV of 90.7%. As
described in the introduction, this PPV makes the
need for confirmation by a second NAAT redun-
dant.6,12
An ideal swab design collects many cells and
allows for their release into media. Copan FLOQs-
wabs are produced by a flocking process, were
short nylon fibre strands are attached to the glued
end of moulded plastic applicators of a desired
shape. The strands are electrostatically charged and
are propelled at high velocity, so that their polar
ends strike the adhesive to bond them perpendicular
to the surface. This process results in a hydrophilic
layer of nylon pile with efficient collection and release
of cells and secretions collected during sampling.16
The analytical advantage of flocked swabs in the
sampling of the urogenital tract has been demon-
strated by several authors. For instance, a study com-
pared flocked swabs in universal transport medium
from Copan Diagnostics to the swabs and transport
tubes from three diagnostic kits for C. trachomatis:
Aptima Combo 2 (Gen-Probe, San Diego, CA,
USA), Amplicor (Roche Molecular Systems,
Montreal, QC, Canada) and ProbeTec ET (Becton
Dickinson Biosciences, Sparks, MD, USA). They
used series of diluted positive mocked C. trachomatis
and Neisseria gonorrhoeae samples. The flocked
swabs showed an equal to better analytical
sensitivity, which may translate to better clinical
sensitivity for C. trachomatis and N. gonorrhoea.16
An improved clinical sensitivity for Trichomonas
vaginalis was found for Copan flocked swabs in a
study comparing self-collected vaginal dacron swabs
using an Aptima collection kit, self-collected vaginal
Copan flocked swabs and first-void urine from 530
women. Both swabs were transported individually
in Aptima specimen transportation media tubes and
T. vaginalis was detected using an Aptima NAAT.
Next to the better performance of the flocked
swabs, the authors stressed the ease of collection
and cost efficiency.17 In another study, a dual collec-
tion device containing flocked and rayon swabs were
used to collect vaginal and cervical samples from 494
women. The swabs were individually transported to
the laboratory in a dry tube environment, where
they were hydrated and tested for high-risk human
papillomavirus (hrHPV) and C. trachomatis with a
Digene hybrid capture two assay (Qiagen, Valencia,
CA, USA) and an in-house RealTime PCR, respect-
ively. The flocked swabs identified more hrHPV and
C. trachomatis infections from both sampling sites,
thereby suggesting a vaginal collection with a flocked
swab to be a viable alternative to cervical swabs in
hrHPV and C. trachomatis screening programmes.18
Next to studies with urogenital samples, several
reports with impressive performances have appeared
evaluating flocked swabs for respiratory sampling.
One study investigated the total respiratory epithelial
cell yield in parallel nasopharyngeal and nasal swabs
sampled with Copan flocked swabs or Copan rayon
swabs taken from 16 healthy volunteers and 61
symptomatic patients. In both groups, a two- to
threefold increase in cell yield with the flocked
design was counted. The authors emphasise the
importance of cell yield for NAAT with respect to
intracellular pathogen detection.19 Indeed, a
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significant concern with regard to the performance of
NAAT has been the cellular adequacy of the cervical
specimen, since C. trachomatis is an intracellular
organism. The presence or absence of cells has been
shown to significantly affect the sensitivity and the
specificity of C. trachomatis detection. However, sev-
eral studies found that samples can test positive for
C. trachomatis in the absence of cells or cellular
DNA as well, due to extracellular bacteria.16,20–22
Other authors found a nasal Copan flocked swab
to surpass traditional nasal aspirates in terms of
PCR-based virus detection. Moreover, clinicians
found flocked swabs easier to evaluate, store and
transport.23 Similar experiments were set up, com-
paring nasal Copan flocked swabs with nasopharyn-
geal aspirates (NPAs) taken from 455 children for the
detection of respiratory viruses. Although no statisti-
cally significant differences were established, the
authors conclude that the excellent sensitivity and
specificity of the flocked swabs, complemented by
the superb feedback from the nursing staff make
them a valid alternative.24 Another group compared
the viral diagnostic yield for respiratory viruses
from Copan flocked swabs with NPAs collected
from 196 children tested by RT-PCR. Although the
authors consider NPAs as the best specimen, more
than acceptable sensitivities were achieved with the
flocked swabs as well.25
Conclusions
Copan FLOQSwabs can be used interchangeably
with Abbott swabs for Abbott RealTime C. tracho-
matis PCR. With the Copan swabs, positivity was
measured in eight Abbott-negative samples, whilst
two samples were only positive with the Abbott
swabs. All of these discordant samples were in the
low analytical test range. Technical issues lead to
retesting of 64 Copan swabs versus 21 Abbott
swabs. Thus, while appearing to have an advantage
in detecting more positive samples, the use of
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